Trastuzumab deruxtecan: An antibody-drug conjugates for non-small cell lung cancer.
This review provides an overview of non-small cell lung cancer (NSCLC) with a focus on the therapeutic role of antibody-...
This review provides an overview of non-small cell lung cancer (NSCLC) with a focus on the therapeutic role of antibody-...
This study presents the cryo-electron microscopy structure of the β-barrel-assembly machinery (BAM) complex from Flavob...
This study evaluates the dual diagnostic utility of metagenomic next-generation sequencing (mNGS) in distinguishing pulm...
This publication reviews the integration of artificial intelligence (AI) with low-dose computed tomography (LDCT) in lun...
The CA209-7AL phase 2 trial evaluated the efficacy and safety of consolidative nivolumab (NIVO) versus observation after...
The publication reports on a phase II clinical trial evaluating the efficacy and safety of a novel targeted therapy in p...